Getting Wegovy in Walsall: What the Process Actually Looks Like

Wegovy (semaglutide) is a once-weekly subcutaneous injection made by Novo Nordisk, licensed in the UK for weight management in adults meeting clinical criteria.
Treatment follows a structured titration schedule (starting at 0.25mg and building toward a maintenance dose) guided entirely by your prescriber, not self-directed.
A new higher dose of 7.2mg was approved by the MHRA in April 2026, meaning the maximum maintenance dose available in the UK is now above the original 2.4mg.
Wegovy works as a GLP-1 receptor agonist: it slows gastric emptying and reduces appetite through gut-hormone pathways, and is taken alongside a reduced-calorie diet and increased physical activity.

If you live in Walsall and are looking into Wegovy for weight management, the honest starting point is this: semaglutide is a prescription-only medicine, which means a qualified prescriber must assess your suitability before any treatment can be supplied. There is no walk-in route. What there is — through a GPhC-registered online pharmacy like nume — is a straightforward clinical consultation that can happen the same day, without a referral or a waiting list, if you meet the licensed criteria. Wegovy is the brand name for semaglutide 2.4mg, a once-weekly injection licensed in the UK for weight management in adults with a BMI of 30 or above, or 27 and above alongside at least one weight-related health condition such as high blood pressure or raised cholesterol. Lower BMI thresholds can apply for some ethnic backgrounds under UK guidance.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

How accessing Wegovy from Walsall works in practice, step by step

Step 1: Understanding what the prescription process involves

Because Wegovy is a prescription-only medicine, the first thing that has to happen is a clinical assessment. That is not a formality, it is the part that keeps you safe. A prescriber looks at your BMI, your current health conditions, any medications you take, and your medical history before deciding whether semaglutide is appropriate for you. This is true whether you approach your GP, a specialist weight management service, or a regulated online pharmacy. The semaglutide overview on our site sets out the full clinical picture if you want to read further before starting.

For Walsall residents, the GP route is available but slow. NHS access to Wegovy is currently restricted to specialist weight management services under NICE guidance, and waiting lists are lengthy. A private online pharmacy offers a parallel path: no referral needed, and the consultation happens on the same day you submit it. At nume, a GPhC-registered Independent Prescriber reads your answers personally, a named clinician, not a script.

The eligibility threshold for private treatment follows the licensed indication: BMI 30 or above, or 27 and above with a qualifying condition. Prediabetes, obstructive sleep apnoea, and osteoarthritis are among the conditions that count alongside BMI. Your prescriber weighs the whole picture.

Step 2: The consultation, verification, and what gets reviewed

Once you submit a consultation, several things happen before any medicine is dispensed. At nume, those steps include photo-ID verification, live weight verification on a video call, a check against your Summary Care Record where appropriate, and GP notification in line with GPhC guidance. If you are transferring from another provider or requesting a dose increase, evidence of your current treatment and dose history is reviewed before anything moves forward.

This matters more than it might sound. The MHRA has issued repeated warnings about fake weight-loss pens sold via social media and unverified websites, including counterfeit tirzepatide pens found in an illicit UK manufacturing site in 2025. Sellers offering these medicines without a prescription, at prices far below the market, or via direct-message sales are red flags. Any online pharmacy you use should be verifiable on the GPhC register; that link takes you directly to nume's own registered pharmacy entry.

Once approved, if you order before 12pm Monday to Friday, treatment is dispatched the same day. It arrives the next working day via DPD in plain, unbranded packaging, you get a tracking notification to your phone, so you know exactly when to expect it. The pen itself is a pre-filled injector; your prescriber and the patient information leaflet guide you on injection technique and sites.

Step 3: What to expect once treatment begins

Wegovy follows a gradual titration schedule. Treatment starts at a low dose to give your body time to adjust, then increases in roughly four-week steps up to a maintenance level. The prescriber decides the pace based on how you are tolerating each stage, you do not move yourself along the ladder. The STEP 1 trial, published in the New England Journal of Medicine, found average weight reduction of around 15% over 68 weeks at the 2.4mg maintenance dose among participants without diabetes.

Side effects are mostly gastrointestinal: nausea, loose stools, constipation, reflux, and occasionally fatigue or headache are the most commonly reported. They tend to be most noticeable after starting or after a dose step, and often settle within a week or two. Drinking enough water and eating smaller meals can help. Urgent medical attention is warranted for severe, persistent stomach pain that spreads to the back, this can be a sign of pancreatitis, which the MHRA flagged in a Drug Safety Update in early 2026 as an infrequent but potentially serious effect of GLP-1 medicines. Any suspected side effects can be reported at the MHRA's Yellow Card scheme.

Wegovy is not recommended during pregnancy, whilst breastfeeding, or if you are trying to conceive. It is not licensed for under-18s. If you take the oral contraceptive pill, discuss this with your prescriber before starting, there is guidance on timing additional contraceptive cover during treatment. If you are based in Wales and want to understand how access works where you are, our page on semaglutide in Wales covers the regional picture in detail. People who take oral HRT may be advised to consider transdermal alternatives; your prescriber can talk through this at consultation.

Cost context and whether this is the right moment to start

Private Wegovy treatment costs vary by dose and provider. Since Eli Lilly's September 2025 list-price revision affected the broader market, typical private prices for weight-loss injections have shifted, for context on the current landscape, the Wegovy cost page sets out what the market looks like and what any legitimate price should include. A private prescription should always come with a clinical assessment, a prescriber review, and genuine supply-chain medicine; if a price seems far below the market, that is worth questioning rather than celebrating.

At nume, one price covers the consultation, prescription, the medicine itself, and free next-working-day delivery. There are no subscriptions and no auto-renewals, every repeat order is reviewed clinically before dispatch. We are not the cheapest option available. That is a deliberate position: for a prescription medicine, the number that matters is not the monthly saving, it is whether the supply is genuine, the prescribing is sound, and you have support if something goes wrong.

If you have questions about the process or want to understand whether you are likely to be suitable, our FAQs page covers many of the most common queries, and our contact team is available seven days a week. Patients in Wales can also find specific guidance on whether Wegovy is available in Wales and what the current access routes look like. For a thorough breakdown of how the treatment works, what to expect, and how to get started, our complete guide to Wegovy brings everything together in one place. When you are ready, checking your eligibility takes only a few minutes.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions